title: The effect of Zafirlukast on capsule formation in post-radiation silicone implants.
abstract: Currently, breast cancer represents the most common indication for mastectomy with negative influence on personal perception, sexuality and partnership. Since the introduction of breast implants, silicone, and saline breast implantation have become one of the most common procedures performed by plastic surgeons, not only for aesthetic reasons but also for reconstructive purposes. These women will ultimately be faced with the prospect of capsular contracture. This is especially true in patients receiving radiation therapy, where irradiation increases the risk of complications, capsular contracture and may compromise a favorable aesthetic result. Despite the capsular contracture is the most common complication for both aesthetic and reconstructive breast surgery, the treatment have remained unsolved. Leukotriene antagonists (LTRAs) have emerged as effective prophylactic agents in the management of reactive airway diseases, and recently they have used as an off label prophylactic agent against the capsular contracture after breast augmentation. However up to now there is no any experimental research or clinical study in the medical literature about the effect of Zafirlukast on the capsular formation around irradiated silicone implants.
authors.affiliation: Department of Plastic and Reconstructive Surgery, China Medical University Hospital, 2 Yuh-Der Road, Taichung City, Taiwan. ssapountzis@yahoo.com
authors.forename: Stamatis
authors.initials: S
authors.lastname: Sapountzis
authors.forename: Ji Hoon
authors.initials: JH
authors.lastname: Kim
authors.forename: Daniela
authors.initials: D
authors.lastname: Francescato Veiga
authors.forename: Lydia
authors.initials: L
authors.lastname: Masako Ferreira
mesh_terms: D001667:Binding, Competitive; D018427:Breast Implants / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D006801:Humans; D057910:Implant Capsular Contracture / Q000209:etiology / Q000517:prevention & control*; D007211:Indoles; D020024:Leukotriene Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D008408:Mastectomy; D048448:Phenylcarbamates; D011878:Radiotherapy / Q000009:adverse effects*; D018077:Receptors, Leukotriene / Q000378:metabolism; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D018077:Receptors, Leukotriene; D013449:Sulfonamides; D014105:Tosyl Compounds; C083169:leukotriene D4 receptor; C062735:zafirlukast